Wells Fargo’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$91 Hold
102
﹤0.01% 6028
2025
Q1
$53 Hold
102
﹤0.01% 5975
2024
Q4
$52 Sell
102
-1,000
-91% -$510 ﹤0.01% 5994
2024
Q3
$3.9K Sell
1,102
-6,000
-84% -$21.2K ﹤0.01% 5552
2024
Q2
$56.2K Buy
7,102
+4,967
+233% +$39.3K ﹤0.01% 4887
2024
Q1
$28.9K Sell
2,135
-2,500
-54% -$33.9K ﹤0.01% 5081
2023
Q4
$50.1K Sell
4,635
-5,498
-54% -$59.4K ﹤0.01% 4861
2023
Q3
$65.9K Sell
10,133
-1,198
-11% -$7.79K ﹤0.01% 4690
2023
Q2
$204K Buy
11,331
+11,199
+8,484% +$202K ﹤0.01% 4335
2023
Q1
$3.09K Buy
132
+1
+0.8% +$23 ﹤0.01% 5840
2022
Q4
$3.28K Sell
131
-288
-69% -$7.2K ﹤0.01% 5560
2022
Q3
$13K Buy
419
+3
+0.7% +$93 ﹤0.01% 5252
2022
Q2
$16K Buy
416
+2
+0.5% +$77 ﹤0.01% 5268
2022
Q1
$17K Hold
414
﹤0.01% 5735
2021
Q4
$21K Buy
414
+20
+5% +$1.01K ﹤0.01% 5813
2021
Q3
$26K Buy
394
+333
+546% +$22K ﹤0.01% 5556
2021
Q2
$3K Sell
61
-314
-84% -$15.4K ﹤0.01% 6129
2021
Q1
$20K Sell
375
-5,835
-94% -$311K ﹤0.01% 5796
2020
Q4
$422K Sell
6,210
-1,261
-17% -$85.7K ﹤0.01% 4547
2020
Q3
$286K Sell
7,471
-3,852
-34% -$147K ﹤0.01% 4608
2020
Q2
$437K Buy
11,323
+1,493
+15% +$57.6K ﹤0.01% 4299
2020
Q1
$295K Buy
9,830
+2,395
+32% +$71.9K ﹤0.01% 4282
2019
Q4
$843K Buy
7,435
+3,003
+68% +$340K ﹤0.01% 3904
2019
Q3
$141K Buy
4,432
+2,367
+115% +$75.3K ﹤0.01% 4942
2019
Q2
$88K Buy
2,065
+1,545
+297% +$65.8K ﹤0.01% 5117
2019
Q1
$28K Buy
520
+100
+24% +$5.39K ﹤0.01% 5344
2018
Q4
$12K Sell
420
-4
-0.9% -$114 ﹤0.01% 5524
2018
Q3
$19K Buy
424
+400
+1,667% +$17.9K ﹤0.01% 5490
2018
Q2
$0 Sell
24
-1,647
-99% ﹤0.01% 5983
2018
Q1
$64K Buy
1,671
+116
+7% +$4.44K ﹤0.01% 5207
2017
Q4
$90K Buy
1,555
+1,481
+2,001% +$85.7K ﹤0.01% 5122
2017
Q3
$5K Buy
+74
New +$5K ﹤0.01% 5641